dipyridamole has been researched along with Conjugate Nystagmus in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olaizola Gorbea, F | 1 |
| Alaminos, A | 1 |
| Hederich, F | 1 |
| Núñez, O | 1 |
1 other study available for dipyridamole and Conjugate Nystagmus
| Article | Year |
|---|---|
[Clinical experimentation of the action of dipyridamol on the response to vestibular stimulation (electronystagmography)].
Topics: Adult; Dipyridamole; Electrooculography; Humans; Methods; Nystagmus, Pathologic; Vestibular Function | 1969 |